CorrectionCorrection to: Effects of Simvastatin on Endoplasmic Reticulum Stress-Mediated Apoptosis in Atherosclerotic Calcification Author Information This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. Cardiology Discovery 2(4):p 286, December 2022. | DOI: 10.1097/CD9.0000000000000079 Open Metrics The article “Effects of Simvastatin on Endoplasmic Reticulum Stress-Mediated Apoptosis in Atherosclerotic Calcification” in Cardiology Discovery was published in error under 2 DOI numbers. The correct DOI is 10.1097/CD9.0000000000000050, as it now appears online. The DOI that was used incorrectly, 10.1097/CD9.0000000000000068, is correctly associated with “Rationale and Design of a Randomized Controlled Trial on Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: the BRIGHT-4 Trial”.Copyright © 2022 The Chinese Medical Association, published by Wolters Kluwer Health, Inc.View full article text
